RESOURCES
COVID-19 Business Continuity
RESOURCES
COVID-19 Business Continuity
Although research around the world is being impacted by COVID-19 pandemic, Science 37 has you covered.
Although research around the world is being impacted by COVID-19 pandemic, Science 37 has you covered.
Our COVID-19 business continuity solution can help virtualize study visits for those engaged in research at traditional sites and connect patients with investigators in real time.
Available globally with rapid deployment, this solution helps research continue in an affordable, highly scalable, 21 CFR Part 11–compliant platform with an audit trail.
In addition to enabling on-demand telemedicine, IMP tracking, eConsent, and ePROs with this platform, researchers have the ability to collect a variety of high-level trial data.
Download our Whitepapers
Navigating Clinical Research During Covid-19 Whitepaper
Business Continuity COVID-19 Whitepaper
See More Solutions